We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New MRI Technique May Predict Progress of Dementias

By HospiMedica International staff writers
Posted on 25 Apr 2012
New technology for evaluating brain images offers the potential of employing magnetic resonance imaging (MRI) to predict the rate of progression and physical path of many deteriorating brain disorders.

The technique, developed by San Francisco Veteran’s Administration (VA) Medical Center (SFVAMC; CA, USA) scientists in collaboration with a team led by Bruce Miller, MD, clinical director of the University of California, San Francisco (UCSF) Memory and Aging Center (USA), also supports growing data that dementias spread through the brain along specific neuronal pathways in the same manner as prion diseases.

The scientists employed new computer modeling techniques to predict realistically the physical progression of Alzheimer’s disease (AD) and frontotemporal dementia (FTD) using images of 14 healthy brains. More...
The models were based on whole-brain tractography, an MRI technique that maps the neural pathways that connect different areas of the brain. The spread of disease along those pathways, as predicted by the models, closely correlated with actual MR images of brain degeneration in 18 AD patients and 18 FTD patients.

The study’s findings were published in the March 22, 2012, issue of the journal of Neuron. “The results need to be replicated, but they suggest that, by using this approach, we can predict the location and course of future brain atrophy in Alzheimer’s, FTD, and other degenerative brain diseases, based on just one MRI taken at the outset of the disease,” said senior author Michael Weiner, MD, director of the SFVAMC Center for Imaging of Neurodegenerative Diseases. “This would be extremely useful in planning treatment, and in helping patients and families know what to expect as dementia progresses.”

Dr. Weiner, who is also a UCSF professor of radiology, medicine, psychiatry, and neurology, reported that that the findings were “consistent with an emerging concept that brain damage occurs in these neurodegenerative diseases in a diffusive, prion-like propagation.”

A prion is an infectious, misfolded form of a normal protein. These proteins leave destructive amyloid deposits in the brains in which they develop, causing degeneration and eventual death. They are responsible for Creutzfeldt-Jakob disease in humans and bovine spongiform encephalopathy (mad cow disease), in cattle.

“The idea of a prion-like mode of progression in dementias, which many scientists are beginning to support, is that the misfolded protein in one neuron will infect a neighboring brain cell, causing proteins in that cell to misfold in turn, and that the spread of these misfolded proteins flows along certain networks in the brain,” explained Dr. Weiner. “For instance, in Alzheimer’s, there is a spread of amyloid protein along the memory network. This paper reinforces the idea that the damage occurs progressively along that network and others.”

Dr. Weiner emphasized that Alzheimer’s and frontotemporal dementia “are not infectious diseases” such as Creutzfeldt-Jakob. But he said, “it may be that a little seed of the disease begins in one neuron in the brain and spreads in a similar way--so it’s infectious within the brain, from one neuron to the next.”

Related Links:

San Francisco VA Medical Center
University of California, San Francisco Memory and Aging Center



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.